BMO Capital Markets analyst Evan Seigerman in a note to investors called Gilead’s third-quarter performance “consistent” and ...

Today, Zevia PBC, the zero sugar, naturally sweetened beverage company, announced it is expanding its Walmart distribution this month from +800 stores to now being available nationally in more than 4, ...

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

Take the case of Tony Newberne, a Black gay man who told the B.A.R. that he wants to ... and it was phase three and my doctor said 'I think you would be great.'" Gilead Sciences Inc., which has a lot ...

As election week jitters markets, Reddit celebrates its first-ever profit while an under-the-radar Aussie company shines.

December S&P 500 E-Mini futures (ESZ24) are trending up +2.24% this morning after Republican Donald Trump won the U.S.

December S&P 500 E-Mini futures (ESZ24) are trending up +2.37% this morning as Donald Trump declared victory in the U.S. presidential election, while investors also geared up for the start of the ...

Teva Pharmaceutical Industries Ltd. today announced that Richard Francis, Teva's President and CEO, will present at ... per diluted share)... Gilead Sciences, Inc. announced today that its ...

Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...

Gilead Sciences (NASDAQ:GILD) will release its quarterly earnings report on Wednesday, 2024-11-06. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Gilead ...

November 06, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2024 results of operations. "Gilead’s third quarter results are the strongest of the ...

In a report released yesterday, Tyler Van Buren from TD Cowen maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price target of $95.00. Tyler Van Buren’s rating is ...